Ladenburg initiated coverage of NeuroOne Medical (NMTC) with a Buy rating and $1.45 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMTC:
- NeuroOne Medical completes FDA submission for OneRF Ablation System RF
- NeuroOne Medical confirms ‘no material impact’ from global tariffs
- NeuroOne Medical sees FY25 product revenue $8M-$10M vs. $3.5M last year
- NeuroOne Medical’s OneRF technology featured in Fox News story
- NeuroOne Medical 16M share Spot Secondary priced at 50c
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue